Alzheimer's disease (AD) is a neurodegenerative brain disorder and the most common cause of dementia. New treatments for AD are required due to its increasing prevalence in aging populations. The present study evaluated the effects of the active components of , and on learning and memory impairment, β-amyloid (Aβ) reduction and brain iron load in an APP/PS1 transgenic mouse model of AD.
View Article and Find Full Text PDFAlzheimer's disease (AD) as a neurodegenerative brain disorder is a devastating pathology leading to disastrous cognitive impairments and dementia, associated with major social and economic costs to society. Iron can catalyze damaging free radical reactions. With age, iron accumulates in brain frontal cortex regions and may contribute to the risk of AD.
View Article and Find Full Text PDF